Triple negative breast cancer: current understanding of biology and treatment options

Current Opinion in Obstetrics & Gynecology
Soonmo Peter KangLyndsay Harris

Abstract

We have made remarkable advances in treatment of breast cancer with combination chemotherapies, hormonal therapies, and modern targeted therapies. Triple negative breast cancers carry a poor prognosis, however, and they are insensitive to most available hormonal or targeted therapeutic agents thus far developed. A better understanding of pathophysiology, natural history, and currently available treatment options is necessary to improve outcomes of patients with triple negative breast cancer. Gene expression profiling has allowed us to classify breast cancers into five subtypes based upon distinctive gene expression signatures. This subtyping is prognostic, and the recent literatures suggest that these 'molecular portraits' may be used to predict treatment outcomes in the future. As we prepare for an era of targeted and individualized medicine, limited understanding of triple negative breast cancer biology presents a challenge in developing novel therapies. Identification of more molecular predictive signatures and their prospective validation will enable us to characterize triple negative breast cancers better and design optimal treatment modalities.

References

Jun 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·A M DavidoffJ R Marks
Dec 6, 1989·Journal of the National Cancer Institute·R Callahan, G Campbell
Oct 1, 1984·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G M ClarkW L McGuire
Oct 7, 1994·Science·P A FutrealY Miki
Aug 30, 1997·Lancet·T CrookB A Gusterson
Aug 30, 2000·Nature·C M PerouD Botstein
Nov 15, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J BonneterreM von Euler
Dec 2, 2000·Nature·R Scully, D M Livingston
Dec 19, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D Stoppa-LyonnetB Asselain
Jan 3, 2001·Proceedings of the National Academy of Sciences of the United States of America·C BegerF Wong-Staal
Feb 24, 2001·The New England Journal of Medicine·I HedenfalkG Sauter
Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·T SørlieA L Børresen-Dale
Feb 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles L VogelMichael Press
Feb 2, 2002·Nature·Laura J van 't VeerStephen H Friend
May 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sunil R LakhaniDouglas F Easton
Nov 7, 2002·Cell·Shridar GanesanDavid M Livingston
Jan 17, 2003·Journal of the National Cancer Institute·Gottfried KonecnyDennis J Slamon
Jun 28, 2003·Proceedings of the National Academy of Sciences of the United States of America·Therese SorlieDavid Botstein
Aug 15, 2003·Proceedings of the National Academy of Sciences of the United States of America·Christos SotiriouEdison T Liu
Oct 2, 2003·Journal of the National Cancer Institute·William D FoulkesLars A Akslen
Aug 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Torsten O NielsenCharles M Perou
Oct 29, 2004·Nature Reviews. Cancer·Nicholas TurnerAlan Ashworth
Nov 18, 2004·Journal of the National Cancer Institute·Richard D KennedyD Paul Harkin
Apr 2, 2005·Breast Cancer Research and Treatment·Shanu ModiClifford A Hudis
Jun 9, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·José BaselgaFederico Rojo
Nov 8, 2005·International Journal of Surgical Pathology·V BossuytF A Tavassoli
Dec 13, 2005·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Chad A LivasyCharles M Perou
Feb 14, 2006·Cancer Cell·Andrea L RichardsonShridar Ganesan
Mar 15, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Socorro María Rodríguez-PinillaJosé Palacios
Mar 25, 2006·Journal of Clinical Pathology·S BanerjeeI E Smith
May 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Farin KamangarWilliam F Anderson
Jun 8, 2006·JAMA : the Journal of the American Medical Association·Lisa A CareyRobert C Millikan
Aug 8, 2006·Seminars in Oncology·John Mendelsohn, Jose Baselga

❮ Previous
Next ❯

Citations

Jul 16, 2010·International Journal of Clinical Oncology·Yutaka Yamamoto, Hirotaka Iwase
Jun 20, 2008·Breast Cancer Research and Treatment·Wen-Jin YinZhi-Ming Shao
Jul 25, 2009·Breast Cancer Research and Treatment·Monica BrownMary Pare
Dec 15, 2010·Breast Cancer Research and Treatment·Xiaoxiang ChenYaping Wang
Jan 30, 2010·Cancer Metastasis Reviews·Kelly K Haagenson, Gen Sheng Wu
May 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Eloisi Caldas-LopesGabriela Chiosis
Oct 12, 2011·Current Opinion in Oncology·Sheeba IrshadAndrew Tutt
Jan 7, 2010·American Journal of Clinical Oncology·Seema Harichand-Herdt, Ruth M O'regan
Jul 22, 2009·Applied Immunohistochemistry & Molecular Morphology : AIMM·Enrique LermaJaime Prat
Jul 27, 2010·Breast Cancer Research : BCR·Bassam GhabachGraça M Dores
May 3, 2013·PloS One·Rounak NassirpourMin-Jean Yin
May 8, 2008·International Journal of Biological Sciences·Athanassios VassilopoulosChu-Xia Deng
Sep 2, 2014·American Journal of Obstetrics and Gynecology·G Larry MaxwellJohn I Risinger
Jun 29, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Matthew Trendowski
Feb 18, 2015·Clinical Journal of Oncology Nursing·Yasemin E TurkmanM Tish Knobf
Jul 3, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Sang-Mi WooSeong-Gyu Ko
Mar 1, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Laszlo OtvosEva Surmacz
Jul 26, 2012·Hematology/oncology and Stem Cell Therapy·Omalkhair AbulkhairAbdulmohsen Alkushi
Sep 21, 2013·Annals of Surgical Oncology·Lee J McGhanBarbara A Pockaj
Aug 8, 2018·Molecular Systems Biology·Benjamin D LandryMichael J Lee
Feb 6, 2020·Cell Cycle·Mohammed Hafiz UddinGen Sheng Wu
Aug 8, 2018·Clinical Medicine Insights. Oncology·Homero GonçalvesMaria Teresa Bustamante Teixeira
Jul 1, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Pramod P MehtaMin-Jean Yin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Rebecca DentSteven A Narod
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Linda Vona-DavisGerald Hobbs
Histopathology
Jorge S Reis-Filho, A N J Tutt
The Lancet Oncology
Susan CleatorR Charles Coombes
The Cancer Journal
Antoinette R Tan, Sandra M Swain
© 2021 Meta ULC. All rights reserved